To Assess the Impact of the Enhanced Recovery After Surgery (ERAS) Consensus on the Effectiveness and Prognosis of Patients With Endoscopic Pituitary Tumor Surgery
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test, Behavioral, Device
Study Type: Observational
SUMMARY
The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 75
Healthy Volunteers: f
View:
• Clinical diagnosis of pituitary tumors
• To sign a written informed consent form
Locations
Other Locations
Taiwan
Kaohsiung Chang Gung Memorial Hospital
RECRUITING
Kaohsiung City
Contact Information
Primary
Hung-Chen Wang, MD, PhD
m82whc@gmail.com
+886-975056287
Time Frame
Start Date: 2023-12-12
Estimated Completion Date: 2025-11-30
Participants
Target number of participants: 70
Treatments
Patients with ERAS
In the experimental group (Patients with ERAS), participants will undergo an assessment of the Enhanced Recovery After Surgery (ERAS) consensus items.~The experimental group will complete all the items on the ERAS forms as far as possible. All groups will undergo our routine preoperative evaluation for pituitary tumor surgery, such as cardiopulmonary function, hormone testing, vision and visual field examination, etc. The care during hospitalization and surgery will be the same as previously for patients with pituitary tumors, and the post-discharge outpatient follow-up will also be the same as for patients who have undergone pituitary tumor surgery.
Patients with Regular
In the control group (Patients with Regular), participants will only complete the routine items as before.~All groups will undergo our routine preoperative evaluation for pituitary tumor surgery, such as cardiopulmonary function, hormone testing, vision and visual field examination, etc. The care during hospitalization and surgery will be the same as previously for patients with pituitary tumors, and the post-discharge outpatient follow-up will also be the same as for patients who have undergone pituitary tumor surgery.
Related Therapeutic Areas
Sponsors
Leads: Chang Gung Memorial Hospital